Lipid nanovectors to use non-coding RNA oligonucleotides in glioblastoma in combination with standard therapy – part II
Prof. Giuseppe De Rosa (email@example.com) and Dr. Virginia Campani - Department of Pharmacy, University Federico II of Naples
Prof. Michele Caraglia, Dr. Silvia Zappavigna, and Dr. Marianna Abate - Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, Naples, Italy
Dr. Carlo Leonetti and Dr. Manuela Porru - Department of Research, Diagnosis and Innovate Technologies, Regina Elena National Cancer, Rome, Italy
This is a follow-up study. Please refer to the first project.
For short, this research activity should provide the proof-of-principle for using SANPs as delivery system for miRNA in the treatment of brain tumors, thus supporting the further studies.
Will be added as soon as available.
Hybrid lipid self-assembling nanoparticles for brain delivery of microRNA
Int. J. Pharm. 588, 119693